Latifa Zekri

5PUBLICATIONS
18CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2024
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia.

Sylwia A Stefańczyk, Clara Hayn, Jonas Heitmann

|Mar 06, 2024
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies.

Latifa Zekri, Ilona Hagelstein, Melanie Märklin

|Aug 26, 2022
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.

Sebastian Hörner, Moustafa Moustafa-Oglou, Karin Teppert

|Dec 29, 2020
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer.

Latifa Zekri, Fabian Vogt, Lukas Osburg

Pageof 1